Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04088188
Title Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Academic and Community Cancer Research United



Cisplatin + Gemcitabine + Pemigatinib

Cisplatin + Gemcitabine + Ivosidenib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Recruiting Scottsdale Arizona 85259 United States Details
Mayo Clinic in Florida Withdrawn Jacksonville Florida 32224-9980 United States Details
Emory University Hospital/Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
Mayo Clinic in Rochester Recruiting Rochester Minnesota 55905 United States Details
University of Nebraska Medical Center Recruiting Omaha Nebraska 68198 United States Details
Spartanburg Regional Medical Center Not yet recruiting Forest City North Carolina 28043 United States Details
M D Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Aurora Cancer Care-Milwaukee West Recruiting Wauwatosa Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field